Dr. Mackler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5301 E Huron River Dr
Cancer Care Building
Ypsilanti, MI 48197Phone+1 734-712-1000
Education & Training
University of MichiganFellowship, Hematology and Medical Oncology, 2003 - 2006- University of MichiganResidency, Internal Medicine, 2000 - 2003
Lewis Katz School of Medicine at Temple UniversityClass of 2000
Certifications & Licensure
MI State Medical License 2000 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 12 citationsLow-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple MyelomaSikander Ailawadhi, Rachael Sexton, Suzanne Lentzsch, Muneer H. Abidi, Peter M. Voorhees
Clinical Cancer Research. 2020-08-01 - 42 citationsPhase II Trial of Paclitaxel, Carboplatin and Gemcitabine in Patients With Locally Advanced Carcinoma of the BladderDavid Smith, Niklas J. Mackler, Rodney L. Dunn, Maha Hussain, Darien Wood
The Journal of Urology. 2008-12-01 - 8 citationsPhase II evaluation of oral estramustine, oral etoposide, and intravenous paclitaxel in patients with hormone-sensitive prostate adenocarcinoma.Niklas J. Mackler, Kenneth J. Pienta, Rodney L. Dunn, Kathleen A. Cooney, Bruce G. Redman
Clinical Genitourinary Cancer. 2007-06-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
